J&J says its single dose protects in opposition to breakthrough Covid-19 for as much as 6 months

Johnson & Johnson stated on Thursday {that a} real-world examine confirmed its single shot COVID-19 vaccine protects in opposition to breakthrough infections and hospitalizations for as much as six months.
The examine, sponsored by the vaccine developer, was performed between Jan. 1 and Sept. 7 final yr, earlier than the Omicron variant was found.
It can also be but to be peer-reviewed.
J&J stated safety in opposition to an infection from its single dose vaccine begins to wane solely from the fourth month in comparison with the second month within the case of two-dose vaccines from rivals Pfizer Inc and BioNTech’s in addition to Moderna.
No waning of safety was discovered for ICU admissions for all of the three vaccines, J&J stated.
The firm stated the examine was carried out by accumulating claims and laboratory information masking 168 million folks.